Bookmark
Forward
Explore Literature Results
QuickView for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=31FD067A41084A84C97BE51309D7990D;jsessionid=B07F4CA705D711712CE0D965EF1BD683;jsessionid=4CFEE323F2B79C5D08EBE44EC57C3E12;jsessionid=7C501B87A415F3AEAEC18EC4D166E79F;jsessionid=A300F2AD9BEC5665BAF78583D201A1BC;jsessionid=88579C7B8C7F550CADBE21BD77EC2DD9;jsessionid=B37A39E7BF2251918917C3BD1DBF63A8;jsessionid=A588C04B9C46C65F6D201C869F73D7E5;jsessionid=388C9DF695A7F167114009330BB6FFB5 (gene)
Most Relevant Literature
- Computational analysis predicts the Kaposi's sarcoma-associated herpesvirus tegument protein ORF63 t…
- Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma G…
- Stability of varicella-zoster virus open reading frame 63.
- Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.
- Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for…
Most Relevant Clinical Trials
There were no clinical trials for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=31FD067A41084A84C97BE51309D7990D;jsessionid=B07F4CA705D711712CE0D965EF1BD683;jsessionid=4CFEE323F2B79C5D08EBE44EC57C3E12;jsessionid=7C501B87A415F3AEAEC18EC4D166E79F;jsessionid=A300F2AD9BEC5665BAF78583D201A1BC;jsessionid=88579C7B8C7F550CADBE21BD77EC2DD9;jsessionid=B37A39E7BF2251918917C3BD1DBF63A8;jsessionid=A588C04B9C46C65F6D201C869F73D7E5;jsessionid=388C9DF695A7F167114009330BB6FFB5
Explore Clinical Trials Results
